CA2824024A1 - Variants de tomm40 comme marqueurs genetiques de la maladie d'alzheimer - Google Patents

Variants de tomm40 comme marqueurs genetiques de la maladie d'alzheimer Download PDF

Info

Publication number
CA2824024A1
CA2824024A1 CA2824024A CA2824024A CA2824024A1 CA 2824024 A1 CA2824024 A1 CA 2824024A1 CA 2824024 A CA2824024 A CA 2824024A CA 2824024 A CA2824024 A CA 2824024A CA 2824024 A1 CA2824024 A1 CA 2824024A1
Authority
CA
Canada
Prior art keywords
disease
subject
alzheimer
apoe
age
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2824024A
Other languages
English (en)
Inventor
Allen D. Roses
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zinfandel Pharmaceuticals Inc
Original Assignee
Zinfandel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zinfandel Pharmaceuticals Inc filed Critical Zinfandel Pharmaceuticals Inc
Publication of CA2824024A1 publication Critical patent/CA2824024A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
CA2824024A 2011-01-10 2011-02-17 Variants de tomm40 comme marqueurs genetiques de la maladie d'alzheimer Abandoned CA2824024A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161431294P 2011-01-10 2011-01-10
US61/431,294 2011-01-10
PCT/US2011/025241 WO2012096680A1 (fr) 2011-01-10 2011-02-17 Facteurs de risque pour une maladie et leurs procédés d'utilisation

Publications (1)

Publication Number Publication Date
CA2824024A1 true CA2824024A1 (fr) 2012-07-19

Family

ID=46507376

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2824024A Abandoned CA2824024A1 (fr) 2011-01-10 2011-02-17 Variants de tomm40 comme marqueurs genetiques de la maladie d'alzheimer

Country Status (5)

Country Link
AU (1) AU2011354696B2 (fr)
BR (1) BR112013017444A2 (fr)
CA (1) CA2824024A1 (fr)
MX (1) MX358594B (fr)
WO (1) WO2012096680A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103898233A (zh) * 2014-04-18 2014-07-02 宁波大学 一种辅助诊断冠心病的检测试剂盒及其检测方法
GB201805554D0 (en) * 2018-04-04 2018-05-16 Wren Therapeutics Therapy for protein misfolding disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006295007A1 (en) * 2005-09-22 2007-04-05 Smithkline Beecham (Cork) Limited Combination of rosiglitazone and donepezil for improvement of cognitive function
ME01898B (me) * 2008-08-12 2014-12-20 Zinfandel Pharmaceuticals Inc Metoda za identifikaciju faktora rizika od alchajmerove bolesti

Also Published As

Publication number Publication date
AU2011354696B2 (en) 2015-03-05
AU2011354696A1 (en) 2013-05-02
MX358594B (es) 2018-08-27
WO2012096680A1 (fr) 2012-07-19
MX2013008068A (es) 2014-01-20
BR112013017444A2 (pt) 2016-09-27

Similar Documents

Publication Publication Date Title
US20210095345A1 (en) Method of identifying disease risk factors
US11021751B2 (en) Disease risk factors and methods of use
AU2011354696B2 (en) Disease risk factors and methods of use
AU2013204020B2 (en) Disease risk factors and methods of use
AU2013202634B2 (en) Method of identifying disease risk factors

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20160204

FZDE Discontinued

Effective date: 20190724